id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1977-N-0013-0001,FDA,FDA-1977-N-0013,"Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use; Proposed Amendment of the Tentative Final Monograph; Required Warnings and Other Labeling",Proposed Rule,Notice of Proposed Rulemaking (NPRM),2006-12-19T05:00:00Z,2006,12,2006-12-19T05:00:00Z,2007-06-20T03:59:59Z,2019-03-23T23:59:29Z,E6-21855,0,0,09000064805d7f3f
FDA-2006-N-0237-0001,FDA,FDA-2006-N-0237,Notice of Proposed Rulemaking re Charging for Investigational Drugs,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2006-12-14T05:00:00Z,2006,12,2006-12-14T05:00:00Z,2007-03-21T03:59:59Z,2016-02-12T22:00:43Z,,0,0,0900006480456b5d
FDA-2006-N-0238-0001,FDA,FDA-2006-N-0238,Expanded Access to Investigational Drugs for Treatment Use,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2006-12-14T00:00:00Z,2006,12,2006-12-14T05:00:00Z,2007-03-15T03:59:59Z,2025-05-21T09:01:14Z,06-9684,0,0,0900006480456c8f
FDA-1998-N-0009-0001,FDA,FDA-1998-N-0009,Over-the-Counter Human Drugs; Labeling Requirements; Proposed Rule,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2006-12-12T05:00:00Z,2006,12,2006-12-11T05:00:00Z,2007-04-12T03:59:59Z,2019-10-10T13:24:46Z,,0,0,0900006480558e9b
FDA-2006-N-0178-0001,FDA,FDA-2006-N-0178,General and Plastic Surgery Devices; Reclassification of the Absorbable Hemostatic Device,Proposed Rule,NPR-Notice of Proposed Rule-Making,2006-10-31T05:00:00Z,2006,10,2006-10-30T05:00:00Z,2007-01-30T04:59:59Z,2008-07-07T18:20:13Z,,0,0,0900006480450b90
FDA-2005-N-0464-0008,FDA,FDA-2005-N-0464,"Notice of Extension re Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs; Public Meeting; Extension of Comment Period",Proposed Rule,Extension of Comment Period,2006-10-31T05:00:00Z,2006,10,2006-10-30T05:00:00Z,2007-01-27T04:59:59Z,2016-12-19T17:17:44Z,,0,0,0900006480450c15
FDA-1978-N-0023-0005,FDA,FDA-1978-N-0023,Skin Bleaching Drug Products For Over-the-Counter Human Use; Proposed Rule,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2006-08-29T04:00:00Z,2006,8,2006-08-28T04:00:00Z,2006-12-28T04:59:59Z,2019-09-26T13:15:35Z,E6-14263,0,0,090000648055f1de
FDA-2005-N-0464-0002,FDA,FDA-2005-N-0464,"Proposed rule on Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs (Pages 201-300)",Proposed Rule,Notice of Proposed Rulemaking (NPRM),2006-08-23T04:00:00Z,2006,8,2006-08-23T04:00:00Z,2006-11-28T04:59:59Z,2017-08-15T14:33:55Z,,0,0,0900006480450bee
FDA-2005-N-0464-0001,FDA,FDA-2005-N-0464,"Proposed rule on Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs (Pages 301-319)",Proposed Rule,Notice of Proposed Rulemaking (NPRM),2006-08-23T04:00:00Z,2006,8,2006-08-23T04:00:00Z,2006-11-28T04:59:59Z,2017-08-15T14:32:51Z,,0,0,0900006480450bce
FDA-2005-N-0464-0003,FDA,FDA-2005-N-0464,"Proposed rule on Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs (Pages 1-100)",Proposed Rule,Notice of Proposed Rulemaking (NPRM),2006-08-23T04:00:00Z,2006,8,2006-08-23T04:00:00Z,2006-11-28T04:59:59Z,2017-08-15T14:35:39Z,,0,0,0900006480450bf2
FDA-2005-N-0464-0004,FDA,FDA-2005-N-0464,"Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs (Pages 101-200)",Proposed Rule,Notice of Proposed Rulemaking (NPRM),2006-08-23T04:00:00Z,2006,8,2006-08-23T04:00:00Z,2006-11-28T04:59:59Z,2016-03-14T19:19:42Z,,0,0,0900006480450bf3
FDA-2006-N-0239-0001,FDA,FDA-2006-N-0239,Index of Legally Marketed Unapproved New Animal Drugs for Minor Species; Proposed Rule,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2006-08-22T04:00:00Z,2006,8,2006-08-21T04:00:00Z,2006-11-21T04:59:59Z,2015-12-15T22:00:50Z,,0,0,0900006480456ecf
FDA-1995-N-0063-0010,FDA,FDA-1995-N-0063,"Current Good Manufacturing Practice, Quality Control Procedures, Quality
Factors, Notification Requirements, and Records and Reports for the Production of Infant Formula; Reopening of the Comment Period",Proposed Rule,Reopening of Comment Period,2006-08-01T04:00:00Z,2006,8,2006-07-28T04:00:00Z,2006-09-16T03:59:59Z,2014-07-17T01:05:26Z,,0,0,090000648056cbef
FDA-2006-N-0171-0001,FDA,FDA-2006-N-0171,Blood Vessels Recovered With Organs and Intended for Use in Organ Transplantation; Companion Document to Direct Final Rule; Proposed Rule,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2006-05-18T04:00:00Z,2006,5,2006-05-12T04:00:00Z,2006-07-27T03:59:59Z,2025-05-20T19:58:09Z,06-4370,0,0,0900006480450945
FDA-2005-N-0343-0001,FDA,FDA-2005-N-0343,Notice of Proposed Rule-Making re Medical Gas Containers and Closures; Current Good Manufacturing Practice Requirements,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2006-04-10T04:00:00Z,2006,4,2006-04-07T04:00:00Z,2006-07-11T03:59:59Z,2016-11-19T02:00:53Z,,0,0,090000648044954b
FDA-2005-N-0345-0001,FDA,FDA-2005-N-0345,"Distribution of Blood Derivatives by Registered Blood Establishments that Qualify as Health Care Entities; Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; Policies, Requirements and Administrative Procedures; Proposed Rule",Proposed Rule,Notice of Proposed Rulemaking (NPRM),2006-02-02T05:00:00Z,2006,2,2006-01-31T05:00:00Z,2006-05-03T03:59:59Z,2025-10-16T22:13:32Z,E6-1225,0,0,0900006480449864
FDA-1998-P-0032-0001,FDA,FDA-1998-P-0032,"Listing of Color Additives Exempt From Certification; Food, Drug, and Cosmetic Labeling: Cochineal Extract and Carmine Declaration; Proposed Rule",Proposed Rule,Notice of Proposed Rulemaking (NPRM),2006-01-30T05:00:00Z,2006,1,2006-01-30T05:00:00Z,2006-05-02T03:59:59Z,2016-03-11T17:00:14Z,,0,0,09000064805651d4
FDA-2005-N-0170-0001,FDA,FDA-2005-N-0170,Current Good Manufacturing Practice Regulation and Investigational New Drugs; Companion Document to Direct Final Rule; Proposed Rule,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2006-01-17T05:00:00Z,2006,1,2006-01-12T05:00:00Z,2006-04-04T03:59:59Z,2015-11-19T02:30:48Z,,0,0,0900006480440c01